Évaluation de l'efficacité et de la perception des dispositifs cosmétiques chez les consommateurs

Date de début de l'étude : 5 mai 2025

Inclusion Criteria: * Subject is female or male (approximately 90% female and 10% male) * Subject is between the ages of 35-65 * Male subjects agree to remove all facial hair 24-48 hours prior to each visit and remain clean shaven daily throughout the study * Subject is of any Fitzpatrick (at least one of each, to be recorded) * Subject is of any of the following (Caucasian, African American, Asian, Hispanic) (at least one of each, to be recorded) * Subject has Self-Perceived Sensitive skin or Self-Perceived Non-Sensitive skin (approximately 50% sensitive and 50% non-sensitive) * Subject has the following on face (mild or greater): Fine lines, ≥3 on 10-point scale Wrinkles, ≥3 on 10-point scale Dull skin, ≥3 on 10-point scale Sagging, ≥3 on 10-point scale Uneven skin tone Roughness/texture At least one dark spot * Subject agrees to return all used and unused test materials at the end of the study * Subjects will use their regular SPF product or will use an SPF product provided by the Sponsor (if they do not have an SPF product) and practice sun safe practices for the duration of the study (Hat, sunglasses, etc.) * Subject agrees not to introduce any new cosmetic or toiletry products during the study other than the products provided in this study * Subject is willing to use a cosmetic device on their face * Subject is dependable and able to follow directions as outlined in the protocol and anticipates being available for all study visits * Subject is willing to participate in all study evaluations * Subject is in generally good health and has a current Panelist Profile Form on file at ECRL * Subject agrees to sign a Photography Release Form, providing consent for the capture of digital images for use in relation to this clinical study * Subject has completed a HIPAA Authorization Form in conformance with 45 CFR Parts 160 and 164 * Subject understands and has signed an Informed Consent Form in conformance with 21 CFR Part 50: "Protection of Human Subjects." Exclusion Criteria * Female subject is pregnant, nursing, planning a pregnancy, or not using adequate birth control * Subject has been part of a clinical test for a LED device, microcurrent device or other facial device within the last 6 months * Subject has eye sensitivity to light that may interfere with the use/application of the test product * Subject has received treatment with sympathomimetics, antihistamines, vasoconstrictors, non-steroidal anti-inflammatory agents, and/or systemic or topical corticosteroids within one week prior to initiation of the study * Subject has a history of acute or chronic dermatologic, medical, and/or physical conditions which would, in the opinion of the Principal Investigator, preclude application of the test material and/or could influence the outcome of the study * Subject has a history of atopic eczema, psoriasis, or onychomycosis * Subject chronically uses substances such as alcohol, tobacco, recreational drugs, etc. * Subject is currently taking certain medications which, in the opinion of the Principal Investigator, may interfere with the study * Subject exhibits any facial tattoos/tattooed cosmetics, eyelash extensions, rashes, scratches, scars, or burn marks on the test site (face) which may interfere with the study * Subject has known allergies to skin treatment products or cosmetics, toiletries, and/or topical drugs * Subject is unable to communicate or cooperate with the Principal Investigator, language problems, etc. * Subject is on another study utilizing the same test sites (Face) * Subject is an employee of testing firms/laboratories, cosmetic or raw goods manufacturers or suppliers * Subject has any planned medical or cosmetic procedures planned during the course of the study that, at the discretion of the Principal Investigator, may interfere with the study * Subject has a history of skin cancer, or is currently undergoing treatment for active cancer of any kind * Subject has diabetes.